Edwards Lifesciences Corp (NYSE:EW)
$ 88.83 -1.28 (-1.42%) Market Cap: 53.53 Bil Enterprise Value: 53.30 Bil PE Ratio: 38.29 PB Ratio: 7.52 GF Score: 98/100

Edwards Lifesciences Corp at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 03:40PM GMT
Release Date Price: $71.73 (-0.57%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Good afternoon, and welcome to another session here at the UBS Virtual Healthcare Conference. I'm Matt Taylor, the UBS U.S. medical supplies and device analyst, and I'm really pleased to be joined by management from Edwards Lifesciences. Today, we have with us, Scott Ullem, who's the CFO; and also Mark Wilterding, Head of IR function for the team, along with Oliver Moravcevic from the IR team as well. And so really looking forward to getting some feedback and insights from all these folks on the business as they've had to adapt through COVID.

(Operator Instructions)

Questions & Answers

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

So Scott, just to get started here. Thanks a lot for joining. Wanted to kick things off with just a higher-level question. Maybe you could update us on some of the underlying business trends, what's been going on in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot